Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-060534)

Filing Details

Accession Number:: 0001209191-17-060534
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2017-11-14 10:56:10
Reporting Period:: 2017-11-13

Accepted Time:: 2017-11-14 10:56:10
Original Submission Date:: 2017-11-14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1595097	Corbus Pharmaceuticals Holdings Inc.	CRBP	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1292834	P David Hochman	C/O Corbus Pharmaceuticals Holdings, Inc 100 River Ridge Drive Norwood MA 02062		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-11-13	5,000	$6.90	215,000	No	4	P	Indirect	By NSH 2008 Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By NSH 2008 Family Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	459,500	Direct
Common Stock	4,300	Indirect	By Solomon Asher Hochman Trust of 2005
Common Stock	4,300	Indirect	By Hannah Hochman Trust of 2007
Common Stock	4,300	Indirect	By Judah Herman Hochman Trust of 2009

Footnotes

The transaction code in Column 3 reported on the Form 4 filed on November 14, 2017 was incorrectly stated as "A" and is being corrected herein via this filing.